K V Pharmaceutical Co Cl A (NASDAQOTH:KVPHQ)

CAPS Rating: 2 out of 5

Develops advanced drug delivery technologies which enhance the effectiveness of new therapeutic agents, existing pharmaceutical products and prescription nutritional products.


Player Avatar stockresearcher6 (< 20) Submitted: 11/12/2009 2:01:35 PM : Underperform Start Price: $3.23 KVPHQ Score: +184.36

In reading the SEC filings and the FDA citations, this company on a wholesale basis at almost every site they manage has undermaintained equipment, responded inappropriately or not at all to quality concerns, and run their machinery at rates that were higher than equipment capacity. IMHO this can only mean one thing: lack of attention to quality, excellence and ethics at the highest levels. Read the filings and statements. Each filing for why financial statements are not produced have the statement saying the company has doubts whther or not it will continue to be a "going concern:. This statement is one they legaly must make if they are not sure they will be able to keep the company solvent. Not sure how they will with no production to speak of for most of 2009, recalls, and no current for sale production. This is a long shot people...wait to see how the trials go and whether their board of directors changes. BTW, a good way to post industry leading profits for the short term is to do the things the FDA cited them for...

Featured Broker Partners